ResMed has launched a rebrand to unify its portfolio and reflect its increasing direct-to-consumer engagement.

A study in people with obesity and diabetes again found CagriSema helps people lose weight, but not by enough to clearly ...

Hims & Hers Health (NYSE:HIMS) shares were on a massive run, but that momentum hit a wall recently. Since its peak on ...

Record Inventory Increase Meets Growing Consumer Demand for Healthcare Cost-Saving SolutionsSurge Driven by Ozempic and Zepbound Prescription ...

Researchers at San Jose State University are looking at the benefits of taking a power nap and finding that it can improve brain function, including boosting alertness, mood, memory and more — but how ...

Sahil Bloom, New York Times bestselling author of “The 5 Types of Wealth: A Transformative Guide to Design Your Dream Life,” joins TODAY to share advice for building “wealth” in your life beyond money ...

In its Monday update, the FDA clarified that state-licensed compounding pharmacies and outsourcing facilities — which make ...

Eli Lilly (LLY) believes its experimental weight-loss pill could make GLP-1 treatments more accessible worldwide.

Novo Nordisk’s semaglutide diabetes and weight loss drugs, Ozempic and Wegovy, are no longer officially in shortage in the US ...